CONFERENCE
Date: November 08-09, 2012
City: Istanbul, Turkey
Event type: Round Table
REGISTER NOW
|
|
Genericsweb Pty Ltd.
Established in 1999, GenericsWeb has customers in over 40 countries including legal practices, government departments, consultants and generic manufacturers. GenericsWeb’s Pipeline Patent Intelligence provides the most comprehensive, relevant and accurate patent information available which stems from full dedication to the industry, extensive experience and investment in customer research.
- Market Reports
- News & Press-Releases
Iloprost - Comprehensive patent search
May, 2012
|
US$ 8,250.00 |
Telaprevir - Comprehensive patent search
May, 2012
|
US$ 7,200.00 |
Saxaglitpin - Comprehensive patent search
May, 2012
|
US$ 7,200.00 |
Plerixafor - Comprehensive patent search
May, 2012
|
US$ 7,200.00 |
Nintedanib - Comprehensive patent search
May, 2012
|
US$ 7,200.00 |
Clofarabine - Comprehensive patent search
May, 2012
|
US$ 7,200.00 |
Boceprevir - Comprehensive patent search
May, 2012
|
US$ 7,200.00 |
Abiraterone - Comprehensive patent search
May, 2012
|
US$ 7,200.00 |
Varespladib - Comprehensive patent search
May, 2012
|
US$ 6,400.00 |
Rilpivirine - Comprehensive patent search
May, 2012
|
US$ 6,400.00 |
Lurasidone - Comprehensive patent search
May, 2012
|
US$ 6,400.00 |
Dalcetrapib - Comprehensive patent search
May, 2012
|
US$ 6,400.00 |
Carfilzomib - Comprehensive patent search
May, 2012
|
US$ 6,400.00 |
MDV-3100 - Comprehensive patent search
May, 2012
|
US$ 5,600.00 |
Lisdexamfetamine - Comprehensive patent search
May, 2012
|
US$ 5,600.00 |
Varespladib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May, 2012
|
US$ 1,200.00 |
Nintedanib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May, 2012
|
US$ 1,200.00 |
MDV-3100 - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May, 2012
|
US$ 1,200.00 |
Lurasidone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May, 2012
|
US$ 1,200.00 |
Dalcetrapib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May, 2012
|
US$ 1,200.00 |
Carfilzomib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May, 2012
|
US$ 1,200.00 |
Varespladib - Key patent, SPC, and data exclusivity expiry (7 country coverage)
May, 2012
|
US$ 500.00 |
Nintedanib - Key patent, SPC, and data exclusivity expiry (7 country coverage)
May, 2012
|
US$ 500.00 |
MDV-3100 - Key patent, SPC, and data exclusivity expiry (7 country coverage)
May, 2012
|
US$ 500.00 |
Lurasidone - Key patent, SPC, and data exclusivity expiry (7 country coverage)
May, 2012
|
US$ 500.00 |
Dalcetrapib - Key patent, SPC, and data exclusivity expiry (7 country coverage)
May, 2012
|
US$ 500.00 |
Carfilzomib - Key patent, SPC, and data exclusivity expiry (7 country coverage)
May, 2012
|
US$ 500.00 |
Cinacalcet - Comprehensive patent search
Mar, 2012
|
US$ 6,400.00 |
Tafluprost - Key patent, SPC, and data exclusivity expiry (7 country coverage)
Mar, 2012
|
US$ 500.00 |
Tafluprost - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Mar, 2012
|
US$ 1,200.00 |
Tafluprost - Comprehensive patent search
Mar, 2012
|
US$ 5,600.00 |
Roflumilast - Key patent, SPC, and data exclusivity expiry (7 country coverage)
Mar, 2012
|
US$ 500.00 |
Roflumilast - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Mar, 2012
|
US$ 1,200.00 |
Roflumilast - Comprehensive patent search
Mar, 2012
|
US$ 7,200.00 |
Ridaforolimus - Key patent, SPC, and data exclusivity expiry (7 country coverage)
Mar, 2012
|
US$ 500.00 |
Ridaforolimus - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Mar, 2012
|
US$ 1,200.00 |
Ridaforolimus - Comprehensive patent search
Mar, 2012
|
US$ 6,400.00 |
Palivizumab - Comprehensive patent search
May, 2012
|
US$ 8,250.00 |
Gatifloxacin - Key patent, SPC, and data exclusivity expiry (7 country coverage)
Mar, 2012
|
US$ 500.00 |
Gatifloxacin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Mar, 2012
|
US$ 1,200.00 |
Gatifloxacin - Comprehensive patent search
Mar, 2012
|
US$ 7,200.00 |
Cabazitaxel - Key patent, SPC, and data exclusivity expiry (7 country coverage)
Mar, 2012
|
US$ 500.00 |
Cabazitaxel - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Mar, 2012
|
US$ 1,200.00 |
Cabazitaxel - Comprehensive patent search
Mar, 2012
|
US$ 7,200.00 |
Apixaban - Key patent, SPC, and data exclusivity expiry (7 country coverage)
Mar, 2012
|
US$ 500.00 |
Apixaban - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Mar, 2012
|
US$ 1,200.00 |
Apixaban - Comprehensive patent search
Mar, 2012
|
US$ 5,600.00 |
Telavancin - Comprehensive patent search
Mar, 2012
|
US$ 7,200.00 |
Retigabine - Key patent, SPC, and data exclusivity expiry (7 country coverage)
Mar, 2012
|
US$ 500.00 |
Retigabine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Mar, 2012
|
US$ 1,200.00 |
|
|
